Revenue and net profit fell sharply year-over-year due to lower sales and higher costs, with significant impacts from foreign exchange losses and increased expenses. The acquisition of REGEN Biotech, Inc. drove up goodwill and minority interests.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.